Cargando…

Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours

This retrospective study was undertaken to determine the outcome of patients with non-seminomatous germ cell tumour who achieved a serological complete response but who had residual radiologic abnormalities upon completion of primary platinum-based chemotherapy. This was an analysis of 76 consecutiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Napier, M P, Naraghi, A, Christmas, T J, Rustin, G J S
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408794/ https://www.ncbi.nlm.nih.gov/pubmed/11044349 http://dx.doi.org/10.1054/bjoc.2000.1416

Ejemplares similares

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
por: Fosså, S D, et al.
Publicado: (1999)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
por: Bono, J S de, et al.
Publicado: (2000)

Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
por: Gerl, A., et al.
Publicado: (1994)

Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour
por: Johnson, P J, et al.
Publicado: (1999)

Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992)

The changing role of surgery in metastatic non-seminomatous germ cell tumour.
por: Cassidy, J., et al.
Publicado: (1992)

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
por: Fizazi, K, et al.
Publicado: (2002)

The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.
por: Harding, M., et al.
Publicado: (1995)

Surveillance or etoposide-containing combination chemotherapy for stage I non-seminomatous germ cell tumours of the testis (NSGCTT)
por: Colls, B. M.
Publicado: (1994)

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
por: Raghavan, D., et al.
Publicado: (1982)

The role of radiotherapy after chemotherapy in the management of persistent para-aortic nodal disease in non-seminomatous germ cell tumours.
por: Read, G., et al.
Publicado: (1986)

Diagnostic Value of the Texture Analysis Parameters of Retroperitoneal Residual Masses on Computed Tomographic Scan after Chemotherapy in Non-Seminomatous Germ Cell Tumors
por: Fournier, Clémence, et al.
Publicado: (2023)

Distinct Proteomic Profile of Spermatozoa from Men with Seminomatous and Non-Seminomatous Testicular Germ Cell Tumors
por: Panner Selvam, Manesh Kumar, et al.
Publicado: (2020)

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.
por: Tait, D., et al.
Publicado: (1984)

Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study
por: Gaffan, J, et al.
Publicado: (2003)

Approach to chemotherapy for high-risk, stage 1, non-seminomatous, germ cell testicular tumors
por: Anand, Madhur
Publicado: (2021)

Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985.
por: Graham, J., et al.
Publicado: (1988)

The management of low-stage non-seminomatous germ cell tumors
por: Lim, Louise, et al.
Publicado: (2012)

SAT-218 Metastatic Non Seminomatous Germ Cell Tumor Masquerading as Bilateral Adrenal Masses
por: Baral, Neelam, et al.
Publicado: (2020)

Two Cases of Cerebral Sinus Venous Thrombosis Following Chemotherapy for Non-Seminomatous Germ Cell Tumor
por: Papet, C., et al.
Publicado: (2011)

Seminomatous Extragonadal Germ Cell Tumor with Complete Obstruction of the Superior Vena Cava Responding to Intensive Chemotherapy
por: Moritoki, Yoshinobu, et al.
Publicado: (2011)

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists.
por: Cullen, M. H., et al.
Publicado: (1996)

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
por: Gerl, A., et al.
Publicado: (1996)

Outcome of testicular non-seminomatous germ cell tumours: report from a tertiary cancer centre in eastern India
por: Biswas, Bivas, et al.
Publicado: (2021)

Testicular non-seminomatous mixed germ cell tumor with rhabdomyosarcoma and retroperitoneal metastatic mass: A case report
por: Sammour, Mohammed, et al.
Publicado: (2020)

Non-Seminomatous Germ Cell Tumor Metastasis to the Jaw: An Imaging Case Report
por: Siverino, Rita Olivia, et al.
Publicado: (2016)

Non-Seminomatous Germ Cell Tumor Presenting with Superior Vena Cava Syndrome
por: Soriano, Paolo K., et al.
Publicado: (2017)

Development of angiosarcoma in a mediastinal non‐seminomatous germ cell tumor that exhibited growing teratoma syndrome during chemotherapy
por: Matsuoka, Shunichiro, et al.
Publicado: (2018)

Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
por: Hitchins, R. N., et al.
Publicado: (1989)

Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
por: Berney, D M, et al.
Publicado: (2001)

Urethral metastasis from non-seminomatous germ cell tumor: a case report
por: Agarwal, Vijay, et al.
Publicado: (2011)

Bone marrow metastasis in a patient with non‐seminomatous testicular germ cell tumor
por: Ueda, Takashi, et al.
Publicado: (2022)

The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
por: Crawford, S. M., et al.
Publicado: (1989)

Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor
por: Xavier, Rosana, et al.
Publicado: (2020)

Brain angiometastasis from a non-seminomatous germ cell tumor: A case report
por: Monroy-Sosa, Alejandro, et al.
Publicado: (2017)

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
por: McNeish, I A, et al.
Publicado: (2004)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Compliance with follow-up of patients treated for non-seminomatous testicular cancer.
por: Young, B. J., et al.
Publicado: (1991)

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
por: Dearnaley, D P, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_caok7ih76m2nm8lthc1ptaj1a8